Yale Cancer Center (YCC) scientists have filled in a key gap in understanding the unusual route by which the Human papillomavirus (HPV) infects cells.
Drinking artificially-sweetened beverages is associated with a significantly lower risk of colon cancer recurrence and cancer death, a team of investigators led by a Yale Cancer Center scientist has found. The study was published today in the journal The Public Library of Science One.
People who received complementary therapy for curable cancers were more likely to refuse at least one component of their conventional cancer treatment, and were more likely to die as a result, according to researchers from Yale Cancer Center and the Cancer Outcomes, Public Policy and Effectiveness Research Center (COPPER) at Yale School of Medicine. The findings were reported today online in JAMA Oncology.
Experts at Yale Cancer Center say unless you take the right precautions, sun exposure (even if you don't get scorched) can damage your skin, causing wrinkles, age spots and even skin cancer.
Dr. Alesandro Santin Discusses Treatment for Endometrial Cancer
Since their arrivals at Yale within the past six years, Patricia LoRusso (right) and Joseph Paul Eder (center)—shown conferring with Clinical Research Coordinator Alexandra Minnella—have overseen a sharp increase in the number of clinical trials conducted by the Phase I Program at Yale Cancer Center.
Gary Desir has served the School of Medicine with distinction as a researcher, clinician, educator, and administrator. His discovery and further investigation of the flavoprotein renalase are milestones in the understanding of renal and cardiovascular function
For a quarter century, Ginny Grunley, her husband Ken Grunley, president and chief executive officer of Grunley Construction, Inc., and their family have been enthusiastic philanthropists. Their determination to help others has included Ginny volunteering as a court-appointed special advocate for disadvantaged children.
Research suggests the common cold thrives in cooler temperatures. One recent study from Yale University found a seven-degree drop in ambient temperature can mess with your body’s ability to stop cold viruses from proliferating.
Cancer experts debate whether there's a glut of immunotherapy trials.
Utilizing Information Technology to Address Oral Chemotherapy Challenges
Cultural taboos surrounding the disease have lessened, but continued research and education are still needed.
Two Yale research teams recently moved forward into round four of a different kind of March Madness competition. The event, called STAT Madness, aims to raise awareness about scientific breakthroughs from national institutions and is sponsored by the Boston-based news organization STAT.
People who choose to get alternative treatments for cancer tend to have everything else going for them - being happier, younger, wealthier, and more educated.
The new Center for Immuno-Oncology will build on Yale Cancer Center's international leadership in immunobiology, cancer immunology, and development of novel cancer immunotherapies.
As plans for consolidation of cancer care within their borders go forth, the partnership between the Health Ministry, the university, and ASCO will be critical for building a sound educational foundation for their oncology workforce.
Yale Cancer Center (YCC) has launched the Yale Center for Immuno-Oncology (YCIO). The new center will build on YCC’s international leadership in immunobiology, cancer immunology, and development of novel cancer immunotherapies.
A majority of pediatric cancer providers endorse the use of medical marijuana for children with advanced cancer, according to results of a multicenter survey published in Pediatrics.
Dr. Petrylak, Professor of Medicine (Medical Oncology) and of Urology; Co-Director, Signal Transduction Research Program, Yale Cancer Center, considers whether PD-L1 biomarkers are useful in the treatment of bladder cancer.
Older women residing in the U.S territories are less likely to receive recommended or timely care for breast cancer compared with similar women residing in the continental United States, according to Yale researchers.
Women who have one or both breasts removed to treat cancer may have unrealistic expectations about how they’ll feel after that surgery and after breast reconstruction, if they choose that option, a U.S. study suggests. Newsmax Article
Yale School of Public Health researchers have developed a new method to predict likely resistance paths to cancer therapeutics, and a methodology to apply it to one of the most frequent cancer-causing genes.
A new, large study led by researchers at Yale Cancer Center shows people with stage III colon cancer who regularly eat nuts are at significantly lower risk of cancer recurrence and mortality than those who don’t.
Bristol-Myers Squibb Company today announced that Yale Cancer Center has joined the International Immuno-Oncology Network (II-ON), a global peer-to-peer collaboration between Bristol-Myers Squibb and academia that aims to advance translational Immuno-Oncology (I-O) science.
A big breakthrough in the battle against breast cancer may have been found in Connecticut.
Yale researchers have developed a set of synthetic molecules that may help boost the strength of a key, virus-fighting protein.
Yale Cancer Center investigators have demonstrated in a new study that more sophisticated models to assess patient risk for cancer can result in better clinical trials with more definitive results.
Progress in treating lung cancer has been enormous in the past 20 years according to a new review by researchers at Yale Cancer Center.
Yale Cancer Center (YCC) has been awarded a $1 million grant by the Bristol-Myers Squibb Foundation (BSMF) to address health care disparities in cancer care and support.
According to Altmetric, which tracks the distribution and discussion of research papers online, a July article by several Yale physicians is the most-discussed paper ever published in the Journal of the National Cancer Institute (JNCI). The title of this blockbuster: “Use of Alternative Medicine for Cancer and Its Impact on Survival.”
New research by Yale Cancer Center (YCC) researchers shows a majority of pediatric cancer providers endorse the potential use of medical marijuana for children with advanced cancer, although providers who are legally eligible to certify its use are more cautious than those who aren’t.
With November Lung Cancer Awareness Month, experts from Yale Cancer Center talk about lung cancer screening and why it is can save lives.
For some cancer patients, the road to remission and healing can have its share of speed bumps. That’s particularly true of patients with non-small cell lung cancer (NSCLC) who develop a secondary, or acquired, resistance to immunotherapy, which initially was effective against their tumors.
Dr. Rogerio Lilenbaum, a board member of NCCN and Chief Medical Officer of Smilow Cancer Hospital at the Yale Cancer Center said that for nonsmall-cell lung cancer, both panel testing and liquid biopsies are appropriate.
Yale Cancer Center scientists now have made a fundamental discovery about EGFR signaling, reported in the journal Cell, that may open the potential for new types of cancer drugs.
It's been 20 years since the BRCA1 gene was found to predispose women to breast cancer, and researchers at Yale have pinpointed what about the gene's mutation leads to cancer.
More than 20 years after scientists revealed that mutations in the BRCA1 gene predispose women to breast cancer, Yale scientists have pinpointed the molecular mechanism that allows those mutations to wreak their havoc.
With October marking National Breast Cancer Awareness month, a breast cancer expert at Yale Cancer Center, sorts out the facts about breast cancer and offers simple ways to reduce risk.
There is an increased risk of thyroid cancer associated with lower-than-normal thyroid hormone levels, a finding that could have a major impact on patients fighting the disease.
Tumor-destroying vaccines have emerged as a new weapon in the fight against cancer.
Older, terminally ill patients could improve the quality of their last days by accessing hospice services much sooner, according to a Yale School of Medicine-led study.
A multigene panel test could be a useful diagnostic tool to help clinicians identify patients with a hereditary kidney cancer syndrome, according to the results of a study published in Cancer.
Not all kidney cancers are killers, and many small tumors can be left alone or watched over time because there is a low risk they will become dangerous, according to Dr. Brian Shuch at the Yale School of Medicine.
Ramucirumab plus docetaxel improves progression-free survival in patients with advanced or metastatic urothelial cancer who have progressed on platinum-based chemotherapy, according to late-breaking results from the phase III RANGE trial presented today at the ESMO 2017 Congress in Madrid (1) to be published in The Lancet (2).
The National Cancer Institute (NCI) has named Peter M. Glazer, M.D., Ph.D., as a recipient of its Outstanding Investigator Award (OIA).
Pancreatic cancer is a particularly deadly form of disease, and patients have few options for effective treatment. But a new Yale Cancer Center study has identified a gene that is critical to pancreatic cancer cell growth, revealing a fresh target for new therapies.
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right